Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers - Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth

被引:218
作者
Cool, CD
Stewart, JS
Werahera, P
Miller, GJ
Williams, RL
Voelkel, NF
Tuder, RW
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Pulm Hypertens Ctr, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Resp & Crit Care Med, Denver, CO 80262 USA
关键词
D O I
10.1016/S0002-9440(10)65137-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The plexiform lesions of severe pulmonary hypertension (PH) are complex vascular structures composed primarily of endothelial cells. In this study, we use immunohistochemical markers to identify the various cell layers of pulmonary vessels and to identify different endothelial cell phenotypes in pulmonary arteries affected by severe PH. Our computerized three-dimensional reconstructions of nine vessels in Eve patients with severe PH demonstrate that plexiform (n = 14) and conceatric-obliterative (n = 6) lesions occur distal to branch points of small pulmonary arteries. And, whereas plexiform lesions occur as solitary lesions, concentric-obliterative lesions appear to be only associated with, and proximal to, plexiform structures. The endothelial cells of plexiform lesions express intensely and uniformly the vascular endothelial growth factor (VEGF) receptor KDR and segregate phenotypically into cyclin-kinase inhibitor p27/kip1-negative cells in the central core of the plexiform lesion and p27/kip1-positive cells in peripheral areas adjacent to incipient blood vessel formation. Using immunohistochemistry and three-dimensional reconstruction techniques, we show that plexiform lesions are dynamic vascular structures characterized by at least two endothelial cell phenotypes. Plexiform arteriopathy is not merely an end stage or postthrombotic change-it may represent one stage in an ongoing, angiogenic endothelial cell growth process.
引用
收藏
页码:411 / 419
页数:9
相关论文
共 32 条
  • [1] BRENOT F, 1993, BRIT HEART J, V70, P537
  • [2] Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection
    Cool, CD
    Kennedy, D
    Voelkel, NF
    Tuder, RM
    [J]. HUMAN PATHOLOGY, 1997, 28 (04) : 434 - 442
  • [3] EDWARDS WD, 1987, CARDIOVASC CLIN, V18, P321
  • [4] The biology of vascular endothelial growth factor
    Ferrara, N
    DavisSmyth, T
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 4 - 25
  • [5] Blood vessel formation: What is its molecular basis?
    Folkman, J
    DAmore, PA
    [J]. CELL, 1996, 87 (07) : 1153 - 1155
  • [6] PRIMARY PULMONARY-HYPERTENSION - NATURAL-HISTORY AND THE IMPORTANCE OF THROMBOSIS
    FUSTER, V
    STEELE, PM
    EDWARDS, WD
    GERSH, BJ
    MCGOON, MD
    FRYE, RL
    [J]. CIRCULATION, 1984, 70 (04) : 580 - 587
  • [7] EXPRESSION OF ENDOTHELIN-1 IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION
    GIAID, A
    YANAGISAWA, M
    LANGLEBEN, D
    MICHEL, RP
    LEVY, R
    SHENNIB, H
    KIMURA, S
    MASAKI, T
    DUGUID, WP
    STEWART, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24) : 1732 - 1739
  • [8] REDUCED EXPRESSION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION
    GIAID, A
    SALEH, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04) : 214 - 221
  • [9] HAWORTH SG, 1998, PATHOLOGY PULM HYPER